The biopharma company will now seek Arikayce’s approval in the US and Japan for use in earlier lines of treatment.

Truist has a ‘Buy’ rating on the shares with a price target of $205, representing a potential upside of about 51% from Friday ...

Add Yahoo as a preferred source to see more of our stories on Google. Few situations are more unsettling than not being able to breathe. Whether from a momentary injury that knocks the wind out of you ...

Insmed Incorporated (NASDAQ:INSM) shares jumped almost 8% in early trade on Monday after the company reported positive ...

Chronic obstructive pulmonary disease, or COPD, is the 5th-leading cause of death in the United States and the cause of more ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...

Chronic obstructive pulmonary disease (COPD) isn’t contagious. But people with COPD can transmit other infections when they cough. They may also have a greater risk of serious illness from a ...

Millions of people living with lung conditions face heightened health risks this winter due to persistent wet weather and the ...

COLUMBUS, Ohio (WCMH) — Members of the central Ohio community gathered at Ohio Stadium Sunday to support clean air and lung ...

Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...